Vyome Biosciences Pvt Ltd:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Vyome Biosciences Pvt Ltd - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C10608
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:19
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:インド
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Vyome Biosciences Pvt Ltd (Vyome) is a clinical-stage biopharmaceutical company that develops novel drugs for antibiotic-resistant acne, other skin pathogens and anti-fungal agents in dermatology. The company’s pipeline products include VB 1953, VB 6345, VB 9333 and VB 9450. Its products are used for antimicrobial resistance development. Vyome develops Dual Action Rational Therapeutics platform and Molecular Replacement Therapeutics platform. The company’s anti-fungal platform technology is used for the treatment of recalcitrant fungal infections. It also develops treatment options for tinea and candida fungi species, skin fungal infection, acne and seborrheic dermatitis. The company has operations in Delhi and Gujarat, India. Vyome is headquartered in New Delhi, Delhi, India.

Vyome Biosciences Pvt Ltd – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Vyome Biosciences Pvt Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Vyome Biosciences Pvt Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Vyome Biosciences Pvt Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Vyome Biosciences Pvt Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Vyome Biosciences Pvt Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Vyome Biosciences Pvt Ltd, Pharmaceuticals & Healthcare, Deal Details 10
Venture Financing 10
Vyome Biosciences Raises USD14 Million in Series C Financing 10
Vyome Biosciences Raises USD8 Million in Series B Venture Financing 11
Vyome Biosciences Raises US$3 Million In Series A Financing 12
Licensing Agreements 13
Vyome Biosciences Enters into Licensing Agreement for Dermatology Products 13
Vyome Biosciences Pvt Ltd – Key Competitors 14
Vyome Biosciences Pvt Ltd – Key Employees 15
Vyome Biosciences Pvt Ltd – Locations And Subsidiaries 16
Head Office 16
Other Locations & Subsidiaries 16
Recent Developments 17
Clinical Trials 17
Apr 24, 2017: Vyome Completes Enrollment for Proof of Concept Clinical Study of VB 1953 17
Feb 07, 2017: Vyome Announces Top-line Results from Phase 1 Study of VB-1953 for Patients with Facial Acne Vulgaris 18
Appendix 19
Methodology 19
About GlobalData 19
Contact Us 19
Disclaimer 19

List of Tables
Vyome Biosciences Pvt Ltd, Pharmaceuticals & Healthcare, Key Facts 2
Vyome Biosciences Pvt Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Vyome Biosciences Pvt Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Vyome Biosciences Pvt Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Vyome Biosciences Pvt Ltd, Deals By Therapy Area, 2012 to YTD 2018 8
Vyome Biosciences Pvt Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Vyome Biosciences Raises USD14 Million in Series C Financing 10
Vyome Biosciences Raises USD8 Million in Series B Venture Financing 11
Vyome Biosciences Raises US$3 Million In Series A Financing 12
Vyome Biosciences Enters into Licensing Agreement for Dermatology Products 13
Vyome Biosciences Pvt Ltd, Key Competitors 14
Vyome Biosciences Pvt Ltd, Key Employees 15
Vyome Biosciences Pvt Ltd, Other Locations 16

List of Figures
Vyome Biosciences Pvt Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Vyome Biosciences Pvt Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Vyome Biosciences Pvt Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Vyome Biosciences Pvt Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Vyome Biosciences Pvt Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Vyome Biosciences Pvt Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Vyome Biosciences Pvt Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Vyome Biosciences Pvt Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

★海外企業調査レポート[Vyome Biosciences Pvt Ltd:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Apex Biotechnology Corp (1733):医療機器:M&Aディール及び事業提携情報
    Summary Apex Biotechnology Corp (ApexBio) is a medical device company that develops, manufactures and commercializes biosensor-based blood glucose monitoring systems. The company provides patient self-testing products, point of care diagnostics and multi-functional products. It also imports and expo …
  • Apple Inc:企業のM&A・事業提携・投資動向
    Apple Inc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Apple Inc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capita …
  • Pakistan Services Ltd.:企業の戦略・SWOT・財務分析
    Pakistan Services Ltd. - Strategy, SWOT and Corporate Finance Report Summary Pakistan Services Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • MMC Corp Bhd (MMCCORP):企業の財務・戦略的SWOT分析
    Summary MMC Corp Bhd (MMC) is an investment holding company which carries out mining, mineral exploration and construction services. It operates through ports and logistics, energy and utilities, engineering and industrial development divisions. The company offers containers, bulk and breakbulk, liq …
  • Polymetal International Plc:企業のM&A・事業提携・投資動向
    Polymetal International Plc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Polymetal International Plc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acq …
  • Magellan Midstream Partners, L.P.:企業の戦略・SWOT・財務情報
    Magellan Midstream Partners, L.P. - Strategy, SWOT and Corporate Finance Report Summary Magellan Midstream Partners, L.P. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, pro …
  • PetroRio SA (PRIO3):石油・ガス:M&Aディール及び事業提携情報
    Summary PetroRio SA (PetroRio), formerly HRT Participacoes em Petroleo SA, a subsidiary of HRT Oil & Gas Ltd, is oil and gas company that offers investment and recovering of oil production assets. The company offers development of solid growth platforms aiming to generate value to its shareholders b …
  • D. Western Therapeutics Institute Inc (4576):製薬・医療:M&Aディール及び事業提携情報
    Summary D. Western Therapeutics Institute Inc (DWTI) is a pharmaceutical product s developer. The company offers ophthalmic solution, WP-1303, H-1337, K-134 and DW-1002. It discovers and develops drugs for glaucoma. DWTI’s ophthalmic solution treats glaucoma and ocular hypertension treatment and art …
  • Indiana University Health Inc:企業の戦略的SWOT分析
    Indiana University Health Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major produ …
  • WPPI Energy, Inc.:企業の戦略的SWOT分析
    WPPI Energy, Inc. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and serv …
  • Achem Technology Corporation:企業の戦略・SWOT・財務分析
    Achem Technology Corporation - Strategy, SWOT and Corporate Finance Report Summary Achem Technology Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • Data Respons ASA (DAT):企業の財務・戦略的SWOT分析
    Summary Data Respons ASA (Data Respons) is an information technology company that offers software products and embedded solutions. The company's products include storage and memory, handheld tablets, embedded boards, panel PCs and displays, systems and platforms, and industrial communication product …
  • Murphy Oil Corp Oil & Gas Exploration and Production Operations and Cost Analysis – Q4, 2017
    Murphy Oil Corp Oil & Gas Exploration and Production Operations and Cost Analysis - Q4, 2017 Summary Murphy Oil Corp (Murphy) is an international independent oil and gas exploration and production company. It explores for and produces crude oil, natural gas, and natural gas liquids. The company oper …
  • Dart Group PLC:企業の戦略・SWOT・財務情報
    Dart Group PLC - Strategy, SWOT and Corporate Finance Report Summary Dart Group PLC - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • Riemser Pharma GmbH:製薬・医療:M&Aディール及び事業提携情報
    Summary Riemser Pharma GmbH (Riemser), formerly Riemser Arzneimittel AG is a distributor of lifecycle management products. The company offers analgesics products, cardiovascular products, over-the-counter medicines, prescription drugs and dental products. It provides medical products for the treatme …
  • Tower International Inc:企業の戦略的SWOT分析
    Tower International Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products an …
  • Medical Facilities Corp (DR):製薬・医療:M&Aディール及び事業提携情報
    Summary Medical Facilities Corp (MFC) is a healthcare service provider that provides inpatient and outpatient surgical procedures. The hospital offers surgical equipment, non-surgical professional services, drugs and supplies, and other support services. Its specialty surgical division performs non- …
  • Bioasis Technologies Inc (BTI):製薬・医療:M&Aディール及び事業提携情報
    Summary Bioasis Technologies Inc (BTI) is a developer and commercialize of pharmaceutical products and diagnostic technologies for central nervous system diseases and disorders. The company’s transcend program describes the proprietary carrier, p97 to deliver therapeutics and imaging agents across t …
  • Autonomous University of Barcelona:製薬・医療:M&Aディール及び事業提携情報
    Summary Autonomous University of Barcelona (UAB) is a public university that offers education, research and knowledge transfer services. The university provides undergraduate, post graduate, masters, doctorates, and foreign undergraduate programs. It offers educational programs in the areas of arts …
  • Edisun Power Europe AG (ESUN):企業の財務・戦略的SWOT分析
    Summary Edisun Power Europe AG (Edisun Power) is a solar power producer. The company finances, develops and operates solar power plants in various European countries. It offers technical studies, legal and financial studies, custom design, installation, work monitoring, and operation and maintenance …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆